These results suggest that the health economic burden of SCCHN is substantial, with costs that are comparable with or higher than those of other solid tumors.
No takes yet. Share an insight, caveat, or question.
Lang et al. (2004) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: